Rznomics

476830· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩28,350-5.18%

2026-10-07

Financials

Valuation Metrics

Rznomics's Market Cap is ₩7954B. At end of 2025 it was ₩2.3T. Ranked #355 of 2,419 in KR market (top 15%), #113 of 1,638 on KOSDAQ (top 7%), #39 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 17%) by Market Cap.

Investment Metrics(as of 2026-10-07)

Metric	Value	Rank
Size
Market Cap	795.37B KRW	KR#355/2,419 Sec#39/231
Revenue	2.00B KRW	KR#2,381/2,419 Sec#215/231
Net Income	-27.61B KRW	KR—/2,419 Sec—/231
Total Assets	51.56B KRW	KR#2,194/2,419 Sec#197/231
Net Assets	46.61B KRW	KR#1,954/2,419 Sec#165/231
Value
P/B	17.07x	KR#2,390/2,419 Sec#219/231
P/S	396.94x	KR#2,404/2,419 Sec#221/231
FCF Yield	-1.37%	KR—/2,419 Sec—/231
Profitability
ROE	-59.24%	KR#2,297/2,419 Sec#203/231
ROA	-53.55%	KR#2,368/2,419 Sec#217/231
Op. Margin	-1418.93%	KR#2,382/2,419 Sec#218/231
Financial Health
Debt Ratio	10.62%	KR#158/2,419 Sec#32/231
FCF	-10.90B KRW	KR#1,733/2,419 Sec#153/231
Cash	6.85B KRW	KR#1,888/2,419 Sec#170/231
Current Ratio	9.68x	KR#103/2,419 Sec#23/231
Performance
1M Return	-1.05%	KR#1,314/2,419 Sec#136/231
From 52W High	-76.88%	KR#2,309/2,419 Sec#212/231
1Y MDD	-82.54%	KR#2,333/2,419 Sec#219/231
Trading
Volume	355,704 shares	KR#346/2,419 Sec#46/231
Trading Value	10.35B KRW	KR#258/2,419 Sec#31/231
Foreign Own.	9.29%	KR#503/2,419 Sec#42/231
Per Share
EPS	-984 KRW	KR—/2,419 Sec—/231
BPS	1,661 KRW	KR#2,157/2,419 Sec#181/231